PT96097A - Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados - Google Patents

Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados

Info

Publication number
PT96097A
PT96097A PT96097A PT9609790A PT96097A PT 96097 A PT96097 A PT 96097A PT 96097 A PT96097 A PT 96097A PT 9609790 A PT9609790 A PT 9609790A PT 96097 A PT96097 A PT 96097A
Authority
PT
Portugal
Prior art keywords
toxoplasma gondii
antibodies
vaccines
derivatives
preparation
Prior art date
Application number
PT96097A
Other languages
English (en)
Other versions
PT96097B (pt
Inventor
Hans Kupper
Stefan Knapp
Robert Ziegelmaier
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of PT96097A publication Critical patent/PT96097A/pt
Publication of PT96097B publication Critical patent/PT96097B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT96097A 1989-12-08 1990-12-06 Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados PT96097B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3940598A DE3940598A1 (de) 1989-12-08 1989-12-08 Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
PT96097A true PT96097A (pt) 1991-09-30
PT96097B PT96097B (pt) 1998-02-27

Family

ID=6395070

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96097A PT96097B (pt) 1989-12-08 1990-12-06 Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados

Country Status (13)

Country Link
US (3) US6022546A (pt)
EP (4) EP0748816B1 (pt)
JP (4) JP3085972B2 (pt)
KR (2) KR100215607B1 (pt)
AT (4) ATE197068T1 (pt)
AU (1) AU629074B2 (pt)
CA (1) CA2031811C (pt)
DE (5) DE3940598A1 (pt)
DK (1) DK0431541T3 (pt)
ES (4) ES2161817T3 (pt)
GR (1) GR3020819T3 (pt)
IE (1) IE75375B1 (pt)
PT (1) PT96097B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542843A4 (en) * 1990-08-10 1994-07-06 Univ Southern Australia Cloning and expression of toxoplasma antigens and use of recombinant antigens
GB9027728D0 (en) * 1990-12-20 1991-02-13 Smithkline Beecham Biolog Novel protein
FR2692282B1 (fr) * 1992-06-15 1995-07-13 Pasteur Institut Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
WO1994017813A1 (en) * 1993-02-08 1994-08-18 Paravax, Inc. Defective sindbis virus vectors that express toxoplasma gondii p30 antigens
ZA958366B (en) * 1994-10-06 1996-04-24 Akzo Nobel Nv New toxoplasma gondii antigens
WO1997027300A1 (en) * 1996-01-26 1997-07-31 Innogenetics N.V. TOXOPLASMA GONDII ANTIGEN Tg20
EP0953641A3 (en) * 1998-03-26 2002-03-13 Pfizer Products Inc. Polynucleotide molecules encoding neospora proteins
AU2006202355B2 (en) * 1998-05-01 2009-08-20 Glaxosmithkline Biologicals Sa Neisseria meningitidis antigens and compositions
US6329157B1 (en) 1998-05-28 2001-12-11 Abbott Laboratories Antigen cocktails and uses thereof
EP1082343A2 (en) * 1998-05-28 2001-03-14 Abbott Laboratories Toxoplasma gondii antigens, p35, and uses thereof
AU4825699A (en) * 1998-06-19 2000-01-05 Genzyme Corporation Identification and use of differentially expressed genes and polynucleotide sequences
BR0308620A (pt) * 2002-03-21 2005-02-15 Kenton S R L Fragmentos de antìgenos para a diagnose de toxoplasma gondii
US7094879B2 (en) 2002-10-02 2006-08-22 Abbott Laboratories Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof
JP4292847B2 (ja) 2003-03-31 2009-07-08 マツダ株式会社 車両のリアバンパー構造
WO2006094665A1 (en) 2005-03-08 2006-09-14 Kenton Srl Chimeric recombinant antigens of toxoplasma gondii
US7432046B2 (en) 2005-11-02 2008-10-07 Abbott Laboratories Methods for the determination of antibody IgG avidity
WO2008051285A2 (en) 2006-04-01 2008-05-02 Medical Service Consultation International, Llc Methods and compositions for detecting fungi and mycotoxins
US20100068718A1 (en) 2008-08-22 2010-03-18 Hooper Dennis G Methods and Compositions for Identifying Yeast
EP2654782A4 (en) * 2010-12-23 2015-03-25 Immport Therapeutics Inc PROCESSES AND COMPOSITIONS FROM PROTEIN ANTIGEN FOR THE DIAGNOSIS AND TREATMENT OF TOXOPLASMA GONDII INFECTIONS AND TOXOPLASMOSIS
CN102313811A (zh) * 2011-09-19 2012-01-11 厦门市仙岳医院 弓形虫IgG抗体胶体金免疫层析检测试剂条及制备方法
CN102305861B (zh) * 2011-09-19 2014-06-18 厦门大学附属中山医院 弓形虫IgM与IgG抗体联合检测试剂条及其制备方法
CN103235119B (zh) * 2013-04-11 2015-09-16 南京农业大学 一种用于弓形虫感染的诊断抗原的应用
KR101682406B1 (ko) * 2016-08-12 2016-12-05 신영기술개발(주) 교량 선배수관 시공방법
CN111116726A (zh) * 2020-01-14 2020-05-08 中国农业科学院北京畜牧兽医研究所 用于检测弓形虫的重组蛋白及其编码基因
CN111265659A (zh) * 2020-02-28 2020-06-12 南京农业大学 一种刚地弓形虫纳米材料亚单位疫苗及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2618680B1 (fr) * 1987-07-31 1990-05-11 Pasteur Institut Antigenes d'excretion-secretion specifiques de toxoplasma gondii, leurs produits d'expression, leur procede d'obtention et leurs applications diagnostiques et prophylactiques
FR2625099B1 (fr) * 1987-12-24 1991-06-14 Transgene Sa Proteines et leur procede de preparation, sequences d'adn, anticorps et leur application, poxvirus, cellules transformees ou infectees et compositions pharmaceutiques utiles dans la prevention de la toxoplasmose
US4877726A (en) * 1988-03-02 1989-10-31 Research Institute Of Palo Alto Medical Foundation Method for the detection of acute-phase toxoplasma infection
US5429922A (en) * 1988-03-09 1995-07-04 The Board Of Trustees Of The Leland Stanford Junior University Composition and method for distinguishing virulent and non-virulent toxoplasma infections
ATE139260T1 (de) * 1988-03-09 1996-06-15 Univ Leland Stanford Junior Diagnostische gene zum nachweis von toxoplasmose

Also Published As

Publication number Publication date
EP0751147B1 (de) 2000-09-06
ES2092483T3 (es) 1996-12-01
GR3020819T3 (en) 1996-11-30
JP3390749B2 (ja) 2003-03-31
IE75375B1 (en) 1997-09-10
KR100215606B1 (en) 1999-08-16
JP2002010794A (ja) 2002-01-15
ES2161817T3 (es) 2001-12-16
EP0431541B1 (de) 1996-08-14
AU6781990A (en) 1991-06-13
JP2002010793A (ja) 2002-01-15
EP0748815B1 (de) 2001-10-04
EP0748816A1 (de) 1996-12-18
ES2152357T3 (es) 2001-02-01
EP0748816B1 (de) 2000-10-18
CA2031811C (en) 2003-05-06
CA2031811A1 (en) 1991-06-09
EP0431541A3 (en) 1992-04-22
ATE206435T1 (de) 2001-10-15
DE59010925D1 (de) 2001-11-08
JP3245143B2 (ja) 2002-01-07
EP0751147A1 (de) 1997-01-02
DE59010915D1 (de) 2000-11-23
DE3940598A1 (de) 1991-06-13
US6022546A (en) 2000-02-08
KR910012244A (ko) 1991-08-07
JPH03197497A (ja) 1991-08-28
EP0431541A2 (de) 1991-06-12
KR100215607B1 (ko) 1999-08-16
ATE197068T1 (de) 2000-11-15
DE59010450D1 (de) 1996-09-19
ATE141289T1 (de) 1996-08-15
IE904426A1 (en) 1991-06-19
JP2000308495A (ja) 2000-11-07
ES2149913T3 (es) 2000-11-16
US6326008B1 (en) 2001-12-04
DE59010913D1 (de) 2000-10-12
DK0431541T3 (da) 1997-01-06
ATE196162T1 (de) 2000-09-15
JP3366628B2 (ja) 2003-01-14
US6419925B1 (en) 2002-07-16
PT96097B (pt) 1998-02-27
JP3085972B2 (ja) 2000-09-11
AU629074B2 (en) 1992-09-24
EP0748815A1 (de) 1996-12-18

Similar Documents

Publication Publication Date Title
PT96097A (pt) Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados
ATE279947T1 (de) Immunglobulinähnliche domäne mit erhöhten halbwertszeiten
ATE348887T1 (de) Streptococcus pneumoniae antigene und impfstoffe
ATE112687T1 (de) Mutanten des hiv-1 hüllproteins mit fehlenden hypervariabelen domänen.
WO1993022332A3 (en) Recombinant production of immunoglobulin-like domains in prokaryotic cells
FI873162A7 (fi) Menetelmä faktori VIII aktiviteetin omaavien proteiinien valmistamiseksi käyttäen mikrobi-isäntäsoluja; ekspressiovektorit, isäntäsolut, vasta-aineet
EP0460076A4 (en) Genetically engineered immunoglobulins
NO872988L (no) Pattedyr-interleukin-4.
DE3584866D1 (de) Hybridpartikel-immunogene.
DE69535719D1 (de) Fas-antigenbindender ligand
GR860914B (en) Expression of immunologically reactive viral proteins
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
SE8105516L (sv) Syntetisk dna och forfarande for framstellning derav
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
EP0293827A3 (en) Assay for leishmaniasis
EP0496787A4 (en) Novel infectious bursal disease virus
Hodges et al. Immunodominant region of EDP 208 pili: Antigen-antibody interaction.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910430

FG3A Patent granted, date of granting

Effective date: 19971118

PC3A Transfer or assignment

Free format text: 19981125 BEHRING DIAGNOSTICS GMBH DE

PD3A Change of proprietorship

Owner name: DADE BEHRING MARBURG GMBH

Effective date: 19981125

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20121119